Summer Jackson
Overview
Explore the profile of Summer Jackson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
969
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mego M, Zuo Z, Gao H, Cohen E, Giordano A, Tin S, et al.
Thromb Haemost
. 2014 Nov;
113(3):593-8.
PMID: 25373787
Cancer is a risk factor for venous thromboembolism (VTE). Elevated plasma D-dimer and fibrinogen levels are also risk factors for VTE. Furthermore, in patients with metastatic breast cancer (MBC), the...
2.
Giuliano M, Giordano A, Jackson S, De Giorgi U, Mego M, Cohen E, et al.
Breast Cancer Res
. 2014 Sep;
16(5):440.
PMID: 25223629
Introduction: Traditional factors currently used for prognostic stratification do not always adequately predict treatment response and disease evolution in advanced breast cancer patients. Therefore, the use of blood-based markers, such...
3.
Giuliano M, Giordano A, Jackson S, Hess K, De Giorgi U, Mego M, et al.
Breast Cancer Res
. 2011 Jun;
13(3):R67.
PMID: 21699723
Introduction: Circulating tumor cells (CTCs) represent an independent predictor of outcome in patients with metastatic breast cancer (MBC). We assessed the prognostic impact of CTCs according to different first-line systemic...
4.
Krishnamurthy S, Cristofanilli M, Singh B, Reuben J, Gao H, Cohen E, et al.
Cancer
. 2010 Jun;
116(14):3330-7.
PMID: 20564098
Background: The significance of circulating tumor cells (CTCs) in blood and of disseminated tumor cells (DTCs) in bone marrow (BM) in patients with early stage breast cancer is unclear. In...
5.
De Giorgi U, Valero V, Rohren E, Dawood S, Ueno N, Miller M, et al.
J Clin Oncol
. 2009 May;
27(20):3303-11.
PMID: 19451443
Purpose: Circulating tumor cells (CTCs) and [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) are two new promising tools for therapeutic monitoring. In this study, we compared the prognostic value...
6.
Dawood S, Broglio K, Valero V, Reuben J, Handy B, Islam R, et al.
Cancer
. 2008 Sep;
113(9):2422-30.
PMID: 18785255
Background: The aim of the current study was to assess the prognostic value of baseline circulating tumor cells (CTCs) in a large cohort of patients with newly diagnosed metastatic breast...
7.
Cristofanilli M, Broglio K, Guarneri V, Jackson S, Fritsche H, Islam R, et al.
Clin Breast Cancer
. 2007 Mar;
7(6):471-9.
PMID: 17386124
Background: The detection of circulating tumor cells (CTCs) predicts overall survival in patients with metastatic breast cancer (MBC). However, it is unknown whether CTCs have superior value compared with other...
8.
Riethdorf S, Fritsche H, Muller V, Rau T, Schindlbeck C, Rack B, et al.
Clin Cancer Res
. 2007 Feb;
13(3):920-8.
PMID: 17289886
Purpose: The CellSearch system (Veridex, Warren, NJ) is designed to enrich and enumerate circulating tumor cells (CTCs) from peripheral blood. Here, we validated the analytic performance of this system for...